560 related articles for article (PubMed ID: 25388058)
1. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
Macias CA; Arumugam D; Arlow RL; Eng OS; Lu SE; Javidian P; Davidov T; Trooskin SZ
Ann Surg Oncol; 2015 May; 22(5):1527-32. PubMed ID: 25388058
[TBL] [Abstract][Full Text] [Related]
2. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
Batawil N; Alkordy T
Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
[TBL] [Abstract][Full Text] [Related]
3. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients.
Rago T; Di Coscio G; Basolo F; Scutari M; Elisei R; Berti P; Miccoli P; Romani R; Faviana P; Pinchera A; Vitti P
Clin Endocrinol (Oxf); 2007 Jan; 66(1):13-20. PubMed ID: 17201796
[TBL] [Abstract][Full Text] [Related]
4. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens.
Kelman AS; Rathan A; Leibowitz J; Burstein DE; Haber RS
Thyroid; 2001 Mar; 11(3):271-7. PubMed ID: 11327619
[TBL] [Abstract][Full Text] [Related]
5. Role of cytological and ultrasonographic features in predicting the risk of malignancy in thyroid nodules with indeterminate cytology.
Saiegh L; Shechner C; Dickstein G; Sheikh-Ahmad M; Reut M; Odeh M; Toubi A; Bejar J
Minerva Endocrinol; 2014 Mar; 39(1):43-52. PubMed ID: 24513603
[TBL] [Abstract][Full Text] [Related]
6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules.
Sahin M; Gursoy A; Tutuncu NB; Guvener DN
Clin Endocrinol (Oxf); 2006 Oct; 65(4):514-8. PubMed ID: 16984245
[TBL] [Abstract][Full Text] [Related]
8. Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.
Tang AL; Falciglia M; Yang H; Mark JR; Steward DL
Thyroid; 2017 Aug; 27(8):1077-1082. PubMed ID: 28657511
[TBL] [Abstract][Full Text] [Related]
9. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
[TBL] [Abstract][Full Text] [Related]
10. Bethesda III thyroid nodules: the role of ultrasound in clinical decision making.
Norlén O; Popadich A; Kruijff S; Gill AJ; Sarkis LM; Delbridge L; Sywak M; Sidhu S
Ann Surg Oncol; 2014 Oct; 21(11):3528-33. PubMed ID: 24806117
[TBL] [Abstract][Full Text] [Related]
11. Fine-needle aspiration of the thyroid: correlating suspicious cytology results with histological outcomes.
Baynes AL; Del Rio A; McLean C; Grodski S; Yeung MJ; Johnson WR; Serpell JW
Ann Surg Oncol; 2014 May; 21(5):1653-8. PubMed ID: 24390657
[TBL] [Abstract][Full Text] [Related]
12. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
Kiernan CM; Solórzano CC
J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
[TBL] [Abstract][Full Text] [Related]
13. Does the presence of additional thyroid nodules on ultrasound alter the risk of malignancy in patients with a follicular neoplasm of the thyroid?
Sippel RS; Elaraj DM; Khanafshar E; Kebebew E; Duh QY; Clark OH
Surgery; 2007 Dec; 142(6):851-7; discussion 857.e1-2. PubMed ID: 18063067
[TBL] [Abstract][Full Text] [Related]
14. Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules.
Méndez W; Rodgers SE; Lew JI; Montano R; Solórzano CC
Ann Surg Oncol; 2008 Sep; 15(9):2487-92. PubMed ID: 18622644
[TBL] [Abstract][Full Text] [Related]
15. Predictors of malignancy in patients with cytologically suspicious thyroid nodules.
Castro MR; Espiritu RP; Bahn RS; Henry MR; Gharib H; Caraballo PJ; Morris JC
Thyroid; 2011 Nov; 21(11):1191-8. PubMed ID: 22007937
[TBL] [Abstract][Full Text] [Related]
16. Thyroid nodule size and prediction of cancer.
Kamran SC; Marqusee E; Kim MI; Frates MC; Ritner J; Peters H; Benson CB; Doubilet PM; Cibas ES; Barletta J; Cho N; Gawande A; Ruan D; Moore FD; Pou K; Larsen PR; Alexander EK
J Clin Endocrinol Metab; 2013 Feb; 98(2):564-70. PubMed ID: 23275525
[TBL] [Abstract][Full Text] [Related]
17. Thyroid Nodule Size at Ultrasound as a Predictor of Malignancy and Final Pathologic Size.
Cavallo A; Johnson DN; White MG; Siddiqui S; Antic T; Mathew M; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2017 May; 27(5):641-650. PubMed ID: 28052718
[TBL] [Abstract][Full Text] [Related]
18. Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS).
Kuru B; Atmaca A; Tarim IA; Kefeli M; Topgul K; Yoruker S; Elmali M; Danaci M
Eur J Surg Oncol; 2016 Jan; 42(1):87-93. PubMed ID: 26527545
[TBL] [Abstract][Full Text] [Related]
19. The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience.
Rossi ED; Straccia P; Martini M; Revelli L; Lombardi CP; Pontecorvi A; Fadda G
Cancer Cytopathol; 2014 May; 122(5):359-67. PubMed ID: 24474727
[TBL] [Abstract][Full Text] [Related]
20. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
